Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurol ; 13(9): 1009-13, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16930369

ABSTRACT

To assess the role of dopamine metabolism-related genes in the genetic liability to chronic headache with drug abuse (DA). We performed a genetic association study using four functional polymorphisms of the dopamine receptor 4 (DRD4), dopamine transporter (DAT), mono-amino-oxidase A (MAOA) and cathecol-O-methyl-transferase (COMT) genes in 103 patients with chronic daily headache associated with DA (CDHDA). Control samples were 117 individuals without headache or DA (controls) and 101 patients with episodic migraine without aura and without DA (MO). No differences were found at the COMT and MAOA genes among the three groups investigated. Allele 4 of DRD4 was significantly overrepresented in patients with MO compared with both controls and CDHDA. Allele 10 of the DAT gene was significantly underrepresented in patients with CDHDA when compared with the MO group. Genetic variability at the DRD4 gene is involved in the predisposition to episodic MO but not to DA, while liability to CDHDA may involve genetic variability at the DAT gene in comparison with episodic MO.


Subject(s)
Dopamine/genetics , Dopamine/metabolism , Genetic Predisposition to Disease , Headache/genetics , Substance-Related Disorders/genetics , Adult , Aged , Aged, 80 and over , Catechol O-Methyltransferase/genetics , Chronic Disease , Dopamine Plasma Membrane Transport Proteins/genetics , Female , Gene Frequency , Genotype , Headache/complications , Humans , Male , Middle Aged , Monoamine Oxidase/genetics , Polymorphism, Genetic , Receptors, Dopamine D4/genetics , Substance-Related Disorders/complications
2.
J Neurophysiol ; 93(6): 3674-86, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15703220

ABSTRACT

A new method is presented based on trinary logic able to check the state of different control variables and synchronously record the physiological and behavioral data of behaving animals and humans. The basic information structure of the method is a time interval of defined maximum duration, called time slice, during which the supervisor system periodically checks the status of a specific subset of input channels. An experimental condition is a sequence of time slices subsequently executed according to the final status of the previous time slice. The proposed method implements in its data structure the possibility to branch like an if-else cascade and the possibility to repeat parts of it recursively like the while-loop. Therefore its data structure contains the most basic control structures of programming languages. The method was implemented using a real-time version of LabVIEW programming environment to program and control our experimental setup. Using this supervision system, we synchronously record four analog data channels at 500 Hz (including eye movements) and the time stamps of up to six neurons at 100 kHz. The system reacts with a resolution within 1 ms to changes of state of digital input channels. The system is set to react to changes in eye position with a resolution within 4 ms. The time slices, experimental conditions, and data are handled by relational databases. This facilitates the construction of new experimental conditions and data analysis. The proposed implementation allows continuous recording without an inter-trial gap for data storage or task management. The implementation can be used to drive electrophysiological experiments of behaving animals and psychophysical studies with human subjects.


Subject(s)
Behavior, Animal/physiology , Computer Systems , Information Storage and Retrieval , Logic , Reaction Time/physiology , Animals , Humans , Time Factors
3.
Neurol Sci ; 24 Suppl 2: S51-6, 2003 May.
Article in English | MEDLINE | ID: mdl-12811592

ABSTRACT

Patients with chronic daily headaches (CDH) bear similarities to drug or substance abuse patients, for whom genetic liability loci have been implicated. We reviewed papers dealing with the metabolic and the genetic aspects of CDH. The relative risk for CDH in first-degree relatives is 2.1- to 3.9-fold increased compared to the general population. Genetic variation at the dopamine receptor 2 has been associated with co-morbidity of migraine with aura with major depression and anxiety, and allele D of the angiotensin converting enzyme increases the frequency of migraine without aura attacks. In CDH, analgesic abuse was significantly associated with specific functional polymorphisms at the DRD 4 and at the dopamine transporter (DAT) genes, findings implicating dopamine-related genes in CDH with drug abuse. CDH carries a substantial genetic predisposition. Molecular genetic studies are, however, still few and preliminary.


Subject(s)
Headache/genetics , Biological Factors , Chronic Disease , Genetic Markers , Genetic Predisposition to Disease , Headache/epidemiology , Humans , Psychology , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL